These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 31202850)
1. Homeobox C8 is a transcriptional repressor of E-cadherin gene expression in non-small cell lung cancer. Zhang J; Yang M; Li D; Zhu S; Zou J; Xu S; Wang Y; Shi J; Li Y Int J Biochem Cell Biol; 2019 Sep; 114():105557. PubMed ID: 31202850 [TBL] [Abstract][Full Text] [Related]
2. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer. Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741 [TBL] [Abstract][Full Text] [Related]
3. Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin. Hou H; Yu X; Cong P; Zhou Y; Xu Y; Jiang Y Cell Prolif; 2019 Jul; 52(4):e12617. PubMed ID: 31012173 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer. Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683 [TBL] [Abstract][Full Text] [Related]
5. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells. Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959 [TBL] [Abstract][Full Text] [Related]
7. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease. Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929 [TBL] [Abstract][Full Text] [Related]
8. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426 [TBL] [Abstract][Full Text] [Related]
9. CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer. Wang J; Wang Y; Sun D; Ren F; Pang S; Xu S Oncol Rep; 2017 May; 37(5):3068-3074. PubMed ID: 28405678 [TBL] [Abstract][Full Text] [Related]
10. Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug. Khan P; Manna A; Saha S; Mohanty S; Mukherjee S; Mazumdar M; Guha D; Das T BMC Cancer; 2016 Jan; 16():39. PubMed ID: 26810856 [TBL] [Abstract][Full Text] [Related]
11. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Dohadwala M; Yang SC; Luo J; Sharma S; Batra RK; Huang M; Lin Y; Goodglick L; Krysan K; Fishbein MC; Hong L; Lai C; Cameron RB; Gemmill RM; Drabkin HA; Dubinett SM Cancer Res; 2006 May; 66(10):5338-45. PubMed ID: 16707460 [TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of BCL6 corepressor-like 1 in non-small cell lung cancer]. Zhao X; Tuo H; Si M; Wang L; Liang P Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1677-81. PubMed ID: 26648304 [TBL] [Abstract][Full Text] [Related]
14. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer. He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression. Miura N; Yano T; Shoji F; Kawano D; Takenaka T; Ito K; Morodomi Y; Yoshino I; Maehara Y Anticancer Res; 2009 Oct; 29(10):4099-106. PubMed ID: 19846957 [TBL] [Abstract][Full Text] [Related]
16. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin. Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087 [TBL] [Abstract][Full Text] [Related]
17. HOXC8 promotes breast tumorigenesis by transcriptionally facilitating cadherin-11 expression. Li Y; Chao F; Huang B; Liu D; Kim J; Huang S Oncotarget; 2014 May; 5(9):2596-607. PubMed ID: 24810778 [TBL] [Abstract][Full Text] [Related]
18. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer. Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834 [TBL] [Abstract][Full Text] [Related]
19. Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673. Wu Y; Niu Y; Leng J; Xu J; Chen H; Li H; Wang L; Hu J; Xia D; Wu Y Toxicol Lett; 2020 Mar; 320():37-45. PubMed ID: 31778776 [TBL] [Abstract][Full Text] [Related]
20. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. Kakihana M; Ohira T; Chan D; Webster RB; Kato H; Drabkin HA; Gemmill RM J Thorac Oncol; 2009 Dec; 4(12):1455-65. PubMed ID: 20009910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]